John B. Landis - Jan 3, 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jan 3, 2025
Transactions value $
$0
Form type
4
Date filed
1/7/2025, 04:04 PM
Previous filing
Jan 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +10K +87.72% $0.00 21.4K Jan 5, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jan 3, 2025 Common Stock 40K $8.26 Direct
transaction EYPT Restricted Stock Units Options Exercise $0 -10K -100% $0.00 0 Jan 5, 2025 Common Stock 10K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested on the one-year anniversary of the grant date.